Time-based Register and Analysis of COPD Endpoints
NCT03485690
COPD, Chronic Disease
Seville, Andalusia, Spain
View Trial DetailsNCT Number: NCT01221480
The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
Looking for future studies?
Notify Me50 year–90 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3000 days
All-cause Mortality
Time frame: 3000 days
Hospital Admissions
Time frame: 3000 days
COPD exacerbations
University of Dundee
Other
Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03485690
COPD, Chronic Disease
Seville, Andalusia, Spain
View Trial DetailsNCT06343324
COPD, Chronic Disease
Konya, Selçuklu, Turkey (Türkiye)
View Trial DetailsNCT07788092
COPD, COPD (Chronic Obstructive Pulmonary Disease)
Perugia, Italy
View Trial DetailsNCT07777497
COPD, Chronic Disease
Kaohsiung City, Sanmin Dist, Taiwan
View Trial Details